Searchable abstracts of presentations at key conferences in endocrinology

ea0020p350 | Diabetes and Cardiovascular | ECE2009

Mildronate positively affects compensation of diabetes in streptozotocin rats and alters iNOS gene expression in rat tissues

Sokolovska Jelizaveta , Kalvinsh Ivars , Sharipova Jelena , Lauberte Lasma , Sjakste Nikolajs

Mildronate, a γ-butyrobetaine analogue is actually used as an antiischemic drug. It was also shown to have effect on mechanisms of glucose utilization.Methods: Diabetes mellitus in Wistar rats was induced by injection of streptozotocin (50 mg/kg). Experimental rats were treatment with Mildronate (100 mg/kg daily, per os) for 6 weeks. Weight, blood glucose concentration, blood triglyceride concentration, blood ketone body concentration, glycat...

ea0032p410 | Diabetes | ECE2013

iNOS, eNOS, and XOR involvement in hyperglycaemia-induced kidney injury in rats with streptozotocin diabetes mellitus

Sokolovska Jelizaveta , Isajevs Sergejs , Sugoka Olga , Baumane Larisa , Isajeva Darja , Sharipova Jelena , Kalvinsh Ivars , Sjakste Nikolajs

Introduction: Diabetic nephropathy is a major complication of diabetes mellitus. Involvement of abnormal nitric oxide (NO) production, both via nitric oxide synthase (NOS) dependent and independent pathways (for example, xantine oxoridoreductase (XOR)) has been discussed. New compounds to treat diabetic nephropathy are searched intensively, some novel dihydropirine class drugs (DHP) have been proposed for this purpose.Aim: To study the changes in NO conc...

ea0026p696 | Diabetes complications | ECE2011

Changes in GLUT1 expression under metformin treatment in rat models of severe and mild stretozotocin diabetes mellitus

Sokolovska Jelizaveta , Isajevs Sergejs , Sugoka Olga , Sharipova Jelena , Lauberte Lasma , Svirina Darja , Rostoka Evita , Sjakste Tatjana , Kalvinsh Ivars , Sjakste Nikolajs

Introduction: Metformin improves hyperglycaemia via mechanisms which include activation of AMP-activated protein kinase (AMPK). Recent findings indicate that some metabolic actions of metformin occur also by AMPK-independent mechanisms.Objective: To study the action of metformin on expression of GLUT1 glucose transporter in rat models of severe and mild stretozotocin diabetes mellitus.Materials and methods: Severe diabetes mellitus...